HK/China Equity Long-Short

Osbert Tang, CFA

Equity Bottom-Up

China International Capital Corporation / Equity Bottom-Up

<ul>
<li>China's securities industry is under a wave of consolidation. <a href="https://www.smartkarma.com/entities/china-international-capital-corporation-ltd" target="_blank" data-smartkarma-citation="entities:1071:1" rel="noopener">China International Capital Corporation (3908 HK)</a> is interesting given its leadership in the investment banking business.</li>
<li>A combination with <a href="https://www.smartkarma.com/entities/china-galaxy-securities-co-h" target="_blank" data-smartkarma-citation="entities:165:1" rel="noopener">China Galaxy Securities (H) (6881 HK)</a> may bring synergy, given their different focuses. This will create the 3rd largest securities house in China. </li>
<li>Even without a merger, CICC also looks attractive with the US interest rate trending down. It is best set to gain upon the revival of the Hong Kong IPO market. </li>
</ul>


China's securities industry is under a wave of consolidation. China International Capital Corporation (3908 HK) is interesting given its leadership in the investment banking business.
A combination with China Galaxy Securities (H) (6881 HK) may bring synergy, given their different focuses. This will create the 3rd largest securities house in China. 
Even without a merger, CICC also looks attractive with the US interest rate trending down. It is best set to gain upon the revival of the Hong Kong IPO market. 


Asian Hedge Fund Manager, Long Short Equity, Macro

David Mudd

Shanghai Electric Group Company / Equity Bottom-Up

<ul>
<li>Hong Kong Long-Only portfolio launched on October 1st with objective to generate alpha in the Hong Kong market.</li>
<li>Stocks are chosen from single stock insights as well as sector and weekly publications.</li>
<li>Positions will be adjusted once a month and the cash position will vary based on market conditions.</li>
</ul>


Hong Kong Long-Only portfolio launched on October 1st with objective to generate alpha in the Hong Kong market.
Stocks are chosen from single stock insights as well as sector and weekly publications.
Positions will be adjusted once a month and the cash position will vary based on market conditions.


China Cinda Asset Management / Equity Bottom-Up

<ul>
<li>China's Ministry of Finance (MOF) has announced plans to sell its stakes in its Asset Management Companies (AMCs) to its sovereign wealth fund, China Investment Corporation (CIC).</li>
<li>The previously announced large debt swap program for LGFVs will ease financing conditions for local governments and should improve distressed debt valuations.</li>
<li>China Cinda Asset Management (1359 HK) will benefit from the PBOC's monetary stimulus program and the support of its new major shareholder with a potential recapitalization.</li>
</ul>


China's Ministry of Finance (MOF) has announced plans to sell its stakes in its Asset Management Companies (AMCs) to its sovereign wealth fund, China Investment Corporation (CIC).
The previously announced large debt swap program for LGFVs will ease financing conditions for local governments and should improve distressed debt valuations.
China Cinda Asset Management (1359 HK) will benefit from the PBOC's monetary stimulus program and the support of its new major shareholder with a potential recapitalization.


HK/CHINA: China Cinda Asset Management a Beneficiary of AMC Restructuring

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyse the changes of A-H premium on 149 stocks over the last week. The average A-H premium was 98.6% as of Nov 1st.</li>
<li>The average A-H premium changed by 2.7ppt week-on-week, led by utilities, information technology, materials.</li>
<li>We highlight weekly changes in A-H premium for Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO.</li>
</ul>


We analyse the changes of A-H premium on 149 stocks over the last week. The average A-H premium was 98.6% as of Nov 1st.
The average A-H premium changed by 2.7ppt week-on-week, led by utilities, information technology, materials.
We highlight weekly changes in A-H premium for Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO.


A-H Premium Weekly (Nov 1st):Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO

<ul>
<li>
<a href="https://www.smartkarma.com/entities/china-international-capital-corporation-ltd" target="_blank" data-smartkarma-citation="entities:1071:1" rel="noopener">China International Capital Corporation (3908 HK)</a> is a laggard among the Chinese securities companies. With the rebound in HSI and Shanghai Composite, such divergence should narrow.</li>
<li>The investment banking business should recover following the rebound in the secondary market and equity valuations. HK's IPO funds raised are forecast to double in 2024.</li>
<li>At 0.4x 12-month P/B, the market has deeply discounted CICC's earnings outlook. However, as earnings recovery will be fast, its share price will react rapidly.</li>
</ul>



China International Capital Corporation (3908 HK) is a laggard among the Chinese securities companies. With the rebound in HSI and Shanghai Composite, such divergence should narrow.
The investment banking business should recover following the rebound in the secondary market and equity valuations. HK's IPO funds raised are forecast to double in 2024.
At 0.4x 12-month P/B, the market has deeply discounted CICC's earnings outlook. However, as earnings recovery will be fast, its share price will react rapidly.


China

China International Capital Corporation Ltd. (CICC) operates as an international investment bank. The Company provides financial services, including investment banking, capital markets, securities sales and trading, fixed income, asset management, and private equity. China International Capital also offers individual wealth management and research services.

China International Capital Corporation (3908 HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China International Capital Corporation (3908 HK)

CICC (3908 HK): M&A Possibility

China's securities industry is consolidating. A potential merger between CICC and CGS could create the 3rd largest securities house in China. CICC...

Osbert Tang, CFA

HONG KONG ALPHA PORTFOLIO - Introduction

We have launched a Hong Kong portfolio with the aim to outperform HK indexes and generate alpha. Stocks are chosen from those highlighted in our...

David Mudd

HK/CHINA: China Cinda Asset Management a Beneficiary of AMC Restructuring

The MOF announced that it is selling its shares in AMCs to China's sovereign wealth fund. This sale as well as recently announced monetary...

David Mudd

A-H Premium Weekly (Nov 1st):Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO.

Ke Yan, CFA, FRM

CICC (3908 HK): Soon to Be Its Time

CICC is a laggard among Chinese securities companies. With the market rebound, its earnings and share price are set to improve rapidly. Its 0.4x P...

Osbert Tang, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

CICC (3908 HK): M&A Possibility

​China's securities industry is consolidating. A potential merger between CICC and CGS could create the 3rd largest securities house in China. CICC...

Osbert Tang, CFA

HONG KONG ALPHA PORTFOLIO - Introduction

We have launched a Hong Kong portfolio with the aim to outperform HK indexes and generate alpha. Stocks are chosen from those highlighted in our...

David Mudd

HK/CHINA: China Cinda Asset Management a Beneficiary of AMC Restructuring

The MOF announced that it is selling its shares in AMCs to China's sovereign wealth fund. This sale as well as recently announced monetary...

David Mudd

A-H Premium Weekly (Nov 1st):Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Chalco, ZOOMLION, FDZJ, FLAT GROUP, RemeGen, CanSinoBIO.

Ke Yan, CFA, FRM

CICC (3908 HK): Soon to Be Its Time

​CICC is a laggard among Chinese securities companies. With the market rebound, its earnings and share price are set to improve rapidly. Its 0.4x P...

Osbert Tang, CFA

China's securities industry is consolidating. A potential merger between CICC and CGS could create the 3rd largest securities house in China. CICC...

CICC is a laggard among Chinese securities companies. With the market rebound, its earnings and share price are set to improve rapidly. Its 0.4x P...